Table 2. The pooled survival rate for the effect of DM on CRC Prognosis.
| Colorectal cancer (%) | Colon cancer (%) | Rectal cancer (%) | |
|---|---|---|---|
| OS | |||
| Patients with DM | 49.8 (45.9, 53.6) | 49.9 (21.5, 78.2) | 50.9 (46.0, 55.8) |
| Patients without DM | 58.1 (53.5, 62.6) | 56.5 (44.1, 68.9) | 64.1 (62.0, 66.3) |
| CVDS | |||
| Patients with DM | 90.5 (85.9, 95.1) | — | — |
| Patients without DM | 94.3 (89.1, 99.5) | — | — |
| CSS | |||
| Patients with DM | 65.6 (61.3, 69.8) | 71.7 (55.1, 88.3) | 67.0 (64.8, 69.2) |
| Patients without DM | 69.0 (63.3, 74.7) | 75.4 (59.4, 91.3) | 74.8 (74.0, 75.7) |
| DFS | |||
| Patients with DM | 60.9 (46.2, 75.5) | 59.3 (37.2, 81.5) | 65.9 (63.0, 68.8) |
| Patients without DM | 70.0 (56.8, 83.3) | 69.5 (48.9, 90.1) | 68.2 (67.2, 69.2) |
| RFS | |||
| Patients with DM | 63.4 (51.9, 74.9) | 57.0 (51.3, 62.7) | — |
| Patients without DM | 68.5 (64.8, 72.3) | 65.0 (63.4, 66.6) | — |
DM: diabetes mellitus; OS: overall survival; CSS: cancer-specific survival; CVDS: cardiovascular disease—specific survival; DFS: disease-free survival; RFS: recurrence-free survival.